(Q48699723)

English

Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer: a phase II study from Indiana University.

scientific article published on 9 November 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16282244

Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer: a phase II study from Indiana University. (English)

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16282244

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A Kurup

1

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16282244

C -W Lin

2

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16282244

D J Murry

3

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16282244

L Dobrolecki

4

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16282244

D Estes

5

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16282244

C T Yiannoutsos

6

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16282244

L Mariano

7

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16282244

C Sidor

8

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16282244

R Hickey

9

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16282244

N Hanna

10

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16282244

publication date

9 November 2005

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16282244

Annals of Oncology

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16282244

17

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16282244

1

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16282244

97-103

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16282244

Clinical applications of angiogenic growth factors and their inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ055

21 January 2018

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ055

21 January 2018

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ055

21 January 2018

Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer a

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ055

21 January 2018

VEGF-Trap: a VEGF blocker with potent antitumor effects

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ055

21 January 2018

Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ055

21 January 2018

The preclinical evaluation of angiogenesis inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ055

21 January 2018

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDJ055

21 January 2018

Identifiers

10.1093/ANNONC/MDJ055

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16282244

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16282244

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48699723&oldid=1568154719"